APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Tumor Screening Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pet Tumor Screening Services Market Analysis and Forecast 2026-2032

4 June 2026231 pages

Choose your research edition.

Industry ResearchPet Tumor Screening Services Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Tumor Screening Services Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pet Tumor Screening Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Tumor Screening Services Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Tumor Screening Services Market Analysis and Forecast 2026-2032231 pages · $4,950 USD

Market perspective

The global Pet Tumor Screening Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pet Tumor Screening Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pet Tumor Screening Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pet Tumor Screening Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pet Tumor Screening Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pet Tumor Screening Services include PetDx, CYTOGEN, BioChain, Small Door, ANGLE, BioChain Institute Inc., CANCAN DIAGNOSTICS., IDEXX Laboratories and Zoetis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pet Tumor Screening Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pet Tumor Screening Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Pet Tumor Screening Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pet Tumor Screening Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Tumor Screening Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pet Tumor Screening Services revenue, projected growth trends, production technology, application and end-user industry.

Pet Tumor Screening Services Segment by Company

PetDx

CYTOGEN

BioChain

Small Door

ANGLE

BioChain Institute Inc.

CANCAN DIAGNOSTICS.

IDEXX Laboratories

Zoetis

VCA Animal Hospitals

AniCura

Anicom Holdings

Tokyo Pet Medical Center

Qiming Pet Hospital

RuiPai Pet

IDK Animal Diagnostics

Beijing Pet Medical Center

Baili Pet Health

Pet Tumor Screening Services Segment by Type

Cut Biopsy

Needle Biopsy

Pet Tumor Screening Services Segment by Application

Pet Hospital

Clinic

Scientific Research Institutions

Pet Tumor Screening Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Tumor Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Tumor Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Tumor Screening Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pet Tumor Screening Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pet Tumor Screening Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Tumor Screening Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Tumor Screening Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cut Biopsy Major Player Table 3. Needle Biopsy Major Player Table 4. Global Pet Tumor Screening Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pet Hospital Major Player Table 6. Clinic Major Player Table 7. Scientific Research Institutions Major Player Table 8. Pet Tumor Screening Services Industry Trends Table 9. Pet Tumor Screening Services Industry Drivers Table 10. Pet Tumor Screening Services Industry Opportunities and Challenges Table 11. Pet Tumor Screening Services Industry Restraints Table 12. Global Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pet Tumor Screening Services Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pet Tumor Screening Services Market Share by Region (2021-2026) Table 15. Global Pet Tumor Screening Services Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pet Tumor Screening Services Market Share by Region (2027-2032) Table 17. Global Pet Tumor Screening Services Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pet Tumor Screening Services Revenue Market Share by Players (2021-2026) Table 19. Global Pet Tumor Screening Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pet Tumor Screening Services Key Players Headquarters & Area Served Table 21. Global Pet Tumor Screening Services Players, Product Type & Application Table 22. Global Pet Tumor Screening Services Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pet Tumor Screening Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pet Tumor Screening Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pet Tumor Screening Services Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Pet Tumor Screening Services Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Pet Tumor Screening Services Revenue Market Share by Type (2021-2026) Table 29. Global Pet Tumor Screening Services Revenue Market Share by Type (2027-2032) Table 30. Global Pet Tumor Screening Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pet Tumor Screening Services Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Pet Tumor Screening Services Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Pet Tumor Screening Services Revenue Market Share by Application (2021-2026) Table 34. Global Pet Tumor Screening Services Revenue Market Share by Application (2027-2032) Table 35. PetDx Company Information Table 36. PetDx Business Overview Table 37. PetDx Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. PetDx Pet Tumor Screening Services Product Portfolio Table 39. PetDx Recent Development Table 40. CYTOGEN Company Information Table 41. CYTOGEN Business Overview Table 42. CYTOGEN Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. CYTOGEN Pet Tumor Screening Services Product Portfolio Table 44. CYTOGEN Recent Development Table 45. BioChain Company Information Table 46. BioChain Business Overview Table 47. BioChain Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BioChain Pet Tumor Screening Services Product Portfolio Table 49. BioChain Recent Development Table 50. Small Door Company Information Table 51. Small Door Business Overview Table 52. Small Door Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Small Door Pet Tumor Screening Services Product Portfolio Table 54. Small Door Recent Development Table 55. ANGLE Company Information Table 56. ANGLE Business Overview Table 57. ANGLE Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. ANGLE Pet Tumor Screening Services Product Portfolio Table 59. ANGLE Recent Development Table 60. BioChain Institute Inc. Company Information Table 61. BioChain Institute Inc. Business Overview Table 62. BioChain Institute Inc. Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. BioChain Institute Inc. Pet Tumor Screening Services Product Portfolio Table 64. BioChain Institute Inc. Recent Development Table 65. CANCAN DIAGNOSTICS. Company Information Table 66. CANCAN DIAGNOSTICS. Business Overview Table 67. CANCAN DIAGNOSTICS. Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. CANCAN DIAGNOSTICS. Pet Tumor Screening Services Product Portfolio Table 69. CANCAN DIAGNOSTICS. Recent Development Table 70. IDEXX Laboratories Company Information Table 71. IDEXX Laboratories Business Overview Table 72. IDEXX Laboratories Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. IDEXX Laboratories Pet Tumor Screening Services Product Portfolio Table 74. IDEXX Laboratories Recent Development Table 75. Zoetis Company Information Table 76. Zoetis Business Overview Table 77. Zoetis Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Zoetis Pet Tumor Screening Services Product Portfolio Table 79. Zoetis Recent Development Table 80. VCA Animal Hospitals Company Information Table 81. VCA Animal Hospitals Business Overview Table 82. VCA Animal Hospitals Pet Tumor Screening Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. VCA Animal Hospitals Pet Tumor Screening Services Product Portfolio Table 84. VCA Animal Hospitals Recent Development Table 85. AniCura Company Information Table 86. AniCura Business Overview Table 87. AniCura Pet Tumor Screening Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. AniCura Pet Tumor Screening Services Product Portfolio Table 89. AniCura Recent Development Table 90. Anicom Holdings Company Information Table 91. Anicom Holdings Business Overview Table 92. Anicom Holdings Pet Tumor Screening Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Anicom Holdings Pet Tumor Screening Services Product Portfolio Table 94. Anicom Holdings Recent Development Table 95. Tokyo Pet Medical Center Company Information Table 96. Tokyo Pet Medical Center Business Overview Table 97. Tokyo Pet Medical Center Pet Tumor Screening Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Tokyo Pet Medical Center Pet Tumor Screening Services Product Portfolio Table 99. Tokyo Pet Medical Center Recent Development Table 100. Qiming Pet Hospital Company Information Table 101. Qiming Pet Hospital Business Overview Table 102. Qiming Pet Hospital Pet Tumor Screening Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Qiming Pet Hospital Pet Tumor Screening Services Product Portfolio Table 104. Qiming Pet Hospital Recent Development Table 105. RuiPai Pet Company Information Table 106. RuiPai Pet Business Overview Table 107. RuiPai Pet Pet Tumor Screening Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. RuiPai Pet Pet Tumor Screening Services Product Portfolio Table 109. RuiPai Pet Recent Development Table 110. IDK Animal Diagnostics Company Information Table 111. IDK Animal Diagnostics Business Overview Table 112. IDK Animal Diagnostics Pet Tumor Screening Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. IDK Animal Diagnostics Pet Tumor Screening Services Product Portfolio Table 114. IDK Animal Diagnostics Recent Development Table 115. Beijing Pet Medical Center Company Information Table 116. Beijing Pet Medical Center Business Overview Table 117. Beijing Pet Medical Center Pet Tumor Screening Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Beijing Pet Medical Center Pet Tumor Screening Services Product Portfolio Table 119. Beijing Pet Medical Center Recent Development Table 120. Baili Pet Health Company Information Table 121. Baili Pet Health Business Overview Table 122. Baili Pet Health Pet Tumor Screening Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Baili Pet Health Pet Tumor Screening Services Product Portfolio Table 124. Baili Pet Health Recent Development Table 125. North America Pet Tumor Screening Services Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Pet Tumor Screening Services Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Pet Tumor Screening Services Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Pet Tumor Screening Services Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Pet Tumor Screening Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Pet Tumor Screening Services Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Pet Tumor Screening Services Revenue by Country (US$ Million) & (2027-2032) Table 132. Europe Pet Tumor Screening Services Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Pet Tumor Screening Services Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Pet Tumor Screening Services Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Pet Tumor Screening Services Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Pet Tumor Screening Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Pet Tumor Screening Services Revenue by Country (2021-2026) & (US$ Million) Table 138. Europe Pet Tumor Screening Services Revenue by Country (US$ Million) & (2027-2032) Table 139. China Pet Tumor Screening Services Revenue by Type (2021-2026) & (US$ Million) Table 140. China Pet Tumor Screening Services Revenue by Type (2027-2032) & (US$ Million) Table 141. China Pet Tumor Screening Services Revenue by Application (2021-2026) & (US$ Million) Table 142. China Pet Tumor Screening Services Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Pet Tumor Screening Services Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Pet Tumor Screening Services Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Pet Tumor Screening Services Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Pet Tumor Screening Services Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Pet Tumor Screening Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Pet Tumor Screening Services Revenue by Region (US$ Million) & (2021-2026) Table 149. Asia Pet Tumor Screening Services Revenue by Region (US$ Million) & (2027-2032) Table 150. SAMEA Pet Tumor Screening Services Revenue by Type (2021-2026) & (US$ Million) Table 151. SAMEA Pet Tumor Screening Services Revenue by Type (2027-2032) & (US$ Million) Table 152. SAMEA Pet Tumor Screening Services Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA Pet Tumor Screening Services Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA Pet Tumor Screening Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. SAMEA Pet Tumor Screening Services Revenue by Country (2021-2026) & (US$ Million) Table 156. SAMEA Pet Tumor Screening Services Revenue by Country (US$ Million) & (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Pet Tumor Screening Services Image Figure 2. Global Pet Tumor Screening Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Tumor Screening Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cut Biopsy Image Figure 5. Needle Biopsy Image Figure 6. Global Pet Tumor Screening Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pet Tumor Screening Services Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pet Hospital Image Figure 9. Clinic Image Figure 10. Scientific Research Institutions Image Figure 11. Global Pet Tumor Screening Services Market Size (US$ Million) & (2021-2032) Figure 12. Global Pet Tumor Screening Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pet Tumor Screening Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pet Tumor Screening Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pet Tumor Screening Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pet Tumor Screening Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pet Tumor Screening Services Revenue Market Share by Type (2021-2032) Figure 19. Global Pet Tumor Screening Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pet Tumor Screening Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Pet Tumor Screening Services Revenue Market Share by Application (2021-2032) Figure 22. North America Pet Tumor Screening Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pet Tumor Screening Services Revenue Share by Type (2021-2032) Figure 24. North America Pet Tumor Screening Services Revenue Share by Application (2021-2032) Figure 25. North America Pet Tumor Screening Services Revenue Share by Country (2021-2032) Figure 26. United States Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pet Tumor Screening Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pet Tumor Screening Services Revenue Share by Type (2021-2032) Figure 31. Europe Pet Tumor Screening Services Revenue Share by Application (2021-2032) Figure 32. Europe Pet Tumor Screening Services Revenue Share by Country (2021-2032) Figure 33. Germany Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pet Tumor Screening Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pet Tumor Screening Services Revenue Share by Type (2021-2032) Figure 43. China Pet Tumor Screening Services Revenue Share by Application (2021-2032) Figure 44. Asia Pet Tumor Screening Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pet Tumor Screening Services Revenue Share by Type (2021-2032) Figure 46. Asia Pet Tumor Screening Services Revenue Share by Application (2021-2032) Figure 47. Asia Pet Tumor Screening Services Revenue Share by Region (2021-2032) Figure 48. Japan Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pet Tumor Screening Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pet Tumor Screening Services Revenue Share by Type (2021-2032) Figure 56. SAMEA Pet Tumor Screening Services Revenue Share by Application (2021-2032) Figure 57. SAMEA Pet Tumor Screening Services Revenue Share by Country (2021-2032) Figure 58. Brazil Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pet Tumor Screening Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cut Biopsy
  • Needle Biopsy
Applications
  • Pet Hospital
  • Clinic
  • Scientific Research Institutions
Companies covered
  • PetDx
  • CYTOGEN
  • BioChain
  • Small Door
  • ANGLE
  • BioChain Institute Inc.
  • CANCAN DIAGNOSTICS.
  • IDEXX Laboratories
  • Zoetis
  • VCA Animal Hospitals
  • AniCura
  • Anicom Holdings
  • Tokyo Pet Medical Center
  • Qiming Pet Hospital
  • RuiPai Pet
  • IDK Animal Diagnostics
  • Beijing Pet Medical Center
  • Baili Pet Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pet Tumor Screening Services Market by Type
  3. 1.2.1 Global Pet Tumor Screening Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cut Biopsy
  5. 1.2.3 Needle Biopsy
  6. 1.3 Pet Tumor Screening Services Market by Application
  7. 1.3.1 Global Pet Tumor Screening Services Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pet Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Scientific Research Institutions
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pet Tumor Screening Services Market Dynamics
  1. 2.1 Pet Tumor Screening Services Industry Trends
  2. 2.2 Pet Tumor Screening Services Industry Drivers
  3. 2.3 Pet Tumor Screening Services Industry Opportunities and Challenges
  4. 2.4 Pet Tumor Screening Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pet Tumor Screening Services Market Perspective (2021-2032)
  2. 3.2 Global Pet Tumor Screening Services Growth Trends by Region
  3. 3.2.1 Global Pet Tumor Screening Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pet Tumor Screening Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Pet Tumor Screening Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pet Tumor Screening Services Revenue by Players
  2. 4.1.1 Global Pet Tumor Screening Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Pet Tumor Screening Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pet Tumor Screening Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pet Tumor Screening Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pet Tumor Screening Services Key Players Headquarters & Area Served
  7. 4.4 Global Pet Tumor Screening Services Players, Product Type & Application
  8. 4.5 Global Pet Tumor Screening Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pet Tumor Screening Services Market CR5 and HHI
  11. 4.6.3 2025 Pet Tumor Screening Services Tier 1, Tier 2, and Tier 3
5 Pet Tumor Screening Services Market Size by Type
  1. 5.1 Global Pet Tumor Screening Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pet Tumor Screening Services Revenue by Type (2021-2032)
  3. 5.3 Global Pet Tumor Screening Services Revenue Market Share by Type (2021-2032)
6 Pet Tumor Screening Services Market Size by Application
  1. 6.1 Global Pet Tumor Screening Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pet Tumor Screening Services Revenue by Application (2021-2032)
  3. 6.3 Global Pet Tumor Screening Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 PetDx
  2. 7.1.1 PetDx Company Information
  3. 7.1.2 PetDx Business Overview
  4. 7.1.3 PetDx Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 PetDx Pet Tumor Screening Services Product Portfolio
  6. 7.1.5 PetDx Recent Developments
  7. 7.2 CYTOGEN
  8. 7.2.1 CYTOGEN Company Information
  9. 7.2.2 CYTOGEN Business Overview
  10. 7.2.3 CYTOGEN Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CYTOGEN Pet Tumor Screening Services Product Portfolio
  12. 7.2.5 CYTOGEN Recent Developments
  13. 7.3 BioChain
  14. 7.3.1 BioChain Company Information
  15. 7.3.2 BioChain Business Overview
  16. 7.3.3 BioChain Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BioChain Pet Tumor Screening Services Product Portfolio
  18. 7.3.5 BioChain Recent Developments
  19. 7.4 Small Door
  20. 7.4.1 Small Door Company Information
  21. 7.4.2 Small Door Business Overview
  22. 7.4.3 Small Door Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Small Door Pet Tumor Screening Services Product Portfolio
  24. 7.4.5 Small Door Recent Developments
  25. 7.5 ANGLE
  26. 7.5.1 ANGLE Company Information
  27. 7.5.2 ANGLE Business Overview
  28. 7.5.3 ANGLE Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ANGLE Pet Tumor Screening Services Product Portfolio
  30. 7.5.5 ANGLE Recent Developments
  31. 7.6 BioChain Institute Inc.
  32. 7.6.1 BioChain Institute Inc. Company Information
  33. 7.6.2 BioChain Institute Inc. Business Overview
  34. 7.6.3 BioChain Institute Inc. Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BioChain Institute Inc. Pet Tumor Screening Services Product Portfolio
  36. 7.6.5 BioChain Institute Inc. Recent Developments
  37. 7.7 CANCAN DIAGNOSTICS.
  38. 7.7.1 CANCAN DIAGNOSTICS. Company Information
  39. 7.7.2 CANCAN DIAGNOSTICS. Business Overview
  40. 7.7.3 CANCAN DIAGNOSTICS. Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 CANCAN DIAGNOSTICS. Pet Tumor Screening Services Product Portfolio
  42. 7.7.5 CANCAN DIAGNOSTICS. Recent Developments
  43. 7.8 IDEXX Laboratories
  44. 7.8.1 IDEXX Laboratories Company Information
  45. 7.8.2 IDEXX Laboratories Business Overview
  46. 7.8.3 IDEXX Laboratories Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 IDEXX Laboratories Pet Tumor Screening Services Product Portfolio
  48. 7.8.5 IDEXX Laboratories Recent Developments
  49. 7.9 Zoetis
  50. 7.9.1 Zoetis Company Information
  51. 7.9.2 Zoetis Business Overview
  52. 7.9.3 Zoetis Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Zoetis Pet Tumor Screening Services Product Portfolio
  54. 7.9.5 Zoetis Recent Developments
  55. 7.10 VCA Animal Hospitals
  56. 7.10.1 VCA Animal Hospitals Company Information
  57. 7.10.2 VCA Animal Hospitals Business Overview
  58. 7.10.3 VCA Animal Hospitals Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 VCA Animal Hospitals Pet Tumor Screening Services Product Portfolio
  60. 7.10.5 VCA Animal Hospitals Recent Developments
  61. 7.11 AniCura
  62. 7.11.1 AniCura Company Information
  63. 7.11.2 AniCura Business Overview
  64. 7.11.3 AniCura Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 AniCura Pet Tumor Screening Services Product Portfolio
  66. 7.11.5 AniCura Recent Developments
  67. 7.12 Anicom Holdings
  68. 7.12.1 Anicom Holdings Company Information
  69. 7.12.2 Anicom Holdings Business Overview
  70. 7.12.3 Anicom Holdings Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Anicom Holdings Pet Tumor Screening Services Product Portfolio
  72. 7.12.5 Anicom Holdings Recent Developments
  73. 7.13 Tokyo Pet Medical Center
  74. 7.13.1 Tokyo Pet Medical Center Company Information
  75. 7.13.2 Tokyo Pet Medical Center Business Overview
  76. 7.13.3 Tokyo Pet Medical Center Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Tokyo Pet Medical Center Pet Tumor Screening Services Product Portfolio
  78. 7.13.5 Tokyo Pet Medical Center Recent Developments
  79. 7.14 Qiming Pet Hospital
  80. 7.14.1 Qiming Pet Hospital Company Information
  81. 7.14.2 Qiming Pet Hospital Business Overview
  82. 7.14.3 Qiming Pet Hospital Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Qiming Pet Hospital Pet Tumor Screening Services Product Portfolio
  84. 7.14.5 Qiming Pet Hospital Recent Developments
  85. 7.15 RuiPai Pet
  86. 7.15.1 RuiPai Pet Company Information
  87. 7.15.2 RuiPai Pet Business Overview
  88. 7.15.3 RuiPai Pet Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 RuiPai Pet Pet Tumor Screening Services Product Portfolio
  90. 7.15.5 RuiPai Pet Recent Developments
  91. 7.16 IDK Animal Diagnostics
  92. 7.16.1 IDK Animal Diagnostics Company Information
  93. 7.16.2 IDK Animal Diagnostics Business Overview
  94. 7.16.3 IDK Animal Diagnostics Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 IDK Animal Diagnostics Pet Tumor Screening Services Product Portfolio
  96. 7.16.5 IDK Animal Diagnostics Recent Developments
  97. 7.17 Beijing Pet Medical Center
  98. 7.17.1 Beijing Pet Medical Center Company Information
  99. 7.17.2 Beijing Pet Medical Center Business Overview
  100. 7.17.3 Beijing Pet Medical Center Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Beijing Pet Medical Center Pet Tumor Screening Services Product Portfolio
  102. 7.17.5 Beijing Pet Medical Center Recent Developments
  103. 7.18 Baili Pet Health
  104. 7.18.1 Baili Pet Health Company Information
  105. 7.18.2 Baili Pet Health Business Overview
  106. 7.18.3 Baili Pet Health Pet Tumor Screening Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Baili Pet Health Pet Tumor Screening Services Product Portfolio
  108. 7.18.5 Baili Pet Health Recent Developments
8 North America
  1. 8.1 North America Pet Tumor Screening Services Revenue (2021-2032)
  2. 8.2 North America Pet Tumor Screening Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Pet Tumor Screening Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Pet Tumor Screening Services Revenue by Type (2027-2032)
  5. 8.3 North America Pet Tumor Screening Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Pet Tumor Screening Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Pet Tumor Screening Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Pet Tumor Screening Services Revenue by Application (2027-2032)
  9. 8.5 North America Pet Tumor Screening Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Pet Tumor Screening Services Revenue by Country
  11. 8.6.1 North America Pet Tumor Screening Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pet Tumor Screening Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Pet Tumor Screening Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pet Tumor Screening Services Revenue (2021-2032)
  2. 9.2 Europe Pet Tumor Screening Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pet Tumor Screening Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pet Tumor Screening Services Revenue by Type (2027-2032)
  5. 9.3 Europe Pet Tumor Screening Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pet Tumor Screening Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pet Tumor Screening Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pet Tumor Screening Services Revenue by Application (2027-2032)
  9. 9.5 Europe Pet Tumor Screening Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pet Tumor Screening Services Revenue by Country
  11. 9.6.1 Europe Pet Tumor Screening Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pet Tumor Screening Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pet Tumor Screening Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pet Tumor Screening Services Revenue (2021-2032)
  2. 10.2 China Pet Tumor Screening Services Revenue by Type (2021-2032)
  3. 10.2.1 China Pet Tumor Screening Services Revenue by Type (2021-2026)
  4. 10.2.2 China Pet Tumor Screening Services Revenue by Type (2027-2032)
  5. 10.3 China Pet Tumor Screening Services Revenue Share by Type (2021-2032)
  6. 10.4 China Pet Tumor Screening Services Revenue by Application (2021-2032)
  7. 10.4.1 China Pet Tumor Screening Services Revenue by Application (2021-2026)
  8. 10.4.2 China Pet Tumor Screening Services Revenue by Application (2027-2032)
  9. 10.5 China Pet Tumor Screening Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pet Tumor Screening Services Revenue (2021-2032)
  2. 11.2 Asia Pet Tumor Screening Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pet Tumor Screening Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pet Tumor Screening Services Revenue by Type (2027-2032)
  5. 11.3 Asia Pet Tumor Screening Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pet Tumor Screening Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pet Tumor Screening Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pet Tumor Screening Services Revenue by Application (2027-2032)
  9. 11.5 Asia Pet Tumor Screening Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pet Tumor Screening Services Revenue by Country
  11. 11.6.1 Asia Pet Tumor Screening Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pet Tumor Screening Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pet Tumor Screening Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pet Tumor Screening Services Revenue (2021-2032)
  2. 12.2 SAMEA Pet Tumor Screening Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pet Tumor Screening Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pet Tumor Screening Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pet Tumor Screening Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pet Tumor Screening Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pet Tumor Screening Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pet Tumor Screening Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pet Tumor Screening Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pet Tumor Screening Services Revenue by Country
  11. 12.6.1 SAMEA Pet Tumor Screening Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pet Tumor Screening Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pet Tumor Screening Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst